MITOMYCIN
Generic: MITOMYCIN
BluePoint LaboratoriesManufacturer
INTRAVENOUSRoute
MITOMYCINActive Substance
2023-10-30Original Approval
MITOMYCIN is FDA application ANDA216732, sponsored by EUGIA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
363 reports
2
DIARRHOEA
151 reports
3
NAUSEA
131 reports
4
THROMBOCYTOPENIA
107 reports
5
NEUTROPENIA
106 reports
6
DRUG INEFFECTIVE
101 reports
7
DISEASE PROGRESSION
98 reports
8
PANCYTOPENIA
93 reports
9
VOMITING
89 reports
10
FATIGUE
78 reports